img Leseprobe Leseprobe

Integrated Cardiac Safety

Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance

J. Rick Turner, Todd A. Durham

PDF
96,99
Amazon iTunes Thalia.de Weltbild.de Hugendubel Bücher.de ebook.de kobo Osiander Google Books Barnes&Noble bol.com Legimi yourbook.shop Kulturkaufhaus ebooks-center.de
* Affiliatelinks/Werbelinks
Hinweis: Affiliatelinks/Werbelinks
Links auf reinlesen.de sind sogenannte Affiliate-Links. Wenn du auf so einen Affiliate-Link klickst und über diesen Link einkaufst, bekommt reinlesen.de von dem betreffenden Online-Shop oder Anbieter eine Provision. Für dich verändert sich der Preis nicht.

John Wiley & Sons img Link Publisher

Naturwissenschaften, Medizin, Informatik, Technik / Chemie

Beschreibung

The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, government officials, and students.

Rezensionen

(Doody's, April 2009)
"This fills the void for a book addressing the safety issues, especially cardiac safety issues, of therapeutic agents in development. The content is high yield, easy to understand and succinct, covering the multiple steps involved in the drug safety and approval process."

"Turner and Durham's book is well-organized and comprehensive, providing both historical and prospective viewpoints. It provides practical information on drug safety throughout lifecycle development, from molecular biology to postmarketing surveillance. It will be an invaluable source of information for those who want to learn about this area, as well as for basic scientists, clinical investigators, physicians, and regulators currently wrestling with the diverse challenges of cardiac safety."

--Peter K.S. Siegl, Ph.D., Siegl Pharma Consulting LLC

"At a moment in health care history when public policy and the practice of medicine are on a collision course and meta-analysis madness threatens to derail 21st century drug development, Turner and Durham strive to return us to the right path, the Critical Path, brightly lit by practical advice and sound science. This is a timely and important book."

--Peter J. Pitts, PhD, President, Center for Medicine in the Public Interest, Former Associate Commissioner, FDA

"Professors Turner and Durham provide a forward-looking guide to medication safety issues relevant to all classes of pharmaceuticals. And their guidance could not be more timely. The public and policymakers are increasingly--and rightly--focused on safety issues at both the development and postmarketing stages. The authors provide a synthesis of medication safety issues that is comprehensive, accessible, and that speaks to a wide range of health care professionals. Integrated Cardiac Safety is an important, and welcome, work."

--Jay Campbell, JD, RPh, Executive Director, North Carolina Board of Pharmacy
Weitere Titel in dieser Kategorie
Cover Nutraceuticals
Hammad Ullah
Cover Plasmonic Nanomaterials
Clemence Queffelec
Cover Plasmonic Nanomaterials
Clemence Queffelec
Cover Organic Chemistry
Mohamed Elzagheid

Kundenbewertungen

Schlagwörter

Chemie, Statistics, Pharmazeutische Statistik, Statistik, Chemistry, Pharmakologie u. Pharmazeutische Medizin, Pharmaceutical Statistics, Pharmacology & Pharmaceutical Medicine, Drug Discovery & Development, Wirkstoffforschung u. -entwicklung, Medical Science, Medizin